{
  "kind": "treatment",
  "slug": "perphenazine-enanthate",
  "type": "medication",
  "name": "Perphenazine Enanthate",
  "summary": "Perphenazine enanthate is a long-acting injectable typical antipsychotic used in the treatment of schizophrenia and other psychotic disorders.",
  "description": "Perphenazine enanthate is a depot formulation of the phenothiazine antipsychotic perphenazine. It is designed for intramuscular injection, providing a sustained release of the drug over time, which helps maintain consistent plasma levels and improves adherence in patients requiring long-term antipsychotic therapy. It works primarily by blocking dopamine D2 receptors in the brain, reducing symptoms of psychosis.",
  "category": "medications/antipsychotics",
  "tags": [
    "antipsychotic",
    "long-acting injectable",
    "depot",
    "schizophrenia"
  ],
  "metadata": {
    "drug_classes": [
      "Typical Antipsychotic"
    ],
    "therapeutic_categories": [
      "Psychiatry"
    ],
    "mechanism_categories": [
      "Dopamine Blocker"
    ],
    "administration_routes": [
      "Injection"
    ],
    "prescription_status": "Prescription only",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [],
    "age_groups": [
      "Adult",
      "Geriatric"
    ],
    "treatment_duration": [
      "Maintenance"
    ],
    "specialty_areas": [
      "Psychiatry"
    ],
    "fda_approval_year": 1966
  },
  "clinical_metadata": {
    "primary_indications": [
      "Psychosis"
    ],
    "off_label_uses": [
      "Severe agitation in psychotic disorders (maintenance setting)"
    ],
    "contraindications": [
      "Hypersensitivity to perphenazine or phenothiazines",
      "Severe central nervous system depression",
      "Comatose states"
    ],
    "monitoring_required": [
      "Mental status",
      "Extrapyramidal symptoms",
      "Tardive dyskinesia signs",
      "Cardiac function",
      "Liver function tests"
    ],
    "efficacy_rating": {
      "Schizophrenia": 3
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "perphenazine enanthate",
      "long-acting perphenazine injection",
      "depot perphenazine"
    ],
    "synonyms": [
      "Depot perphenazine",
      "Perphenazine LAI"
    ],
    "common_misspellings": [
      "perfenazine",
      "perphenazin",
      "enanthate perphenazine"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Treatment of schizophrenia",
        "Treatment of schizoaffective disorder",
        "Maintenance therapy for chronic psychotic disorders"
      ]
    },
    {
      "type": "mechanism",
      "text": "Perphenazine enanthate exerts its therapeutic effect by antagonizing dopamine D2 receptors in the mesolimbic pathway, reducing hallucinations, delusions, and thought disorder. The depot formulation releases the drug slowly over weeks."
    },
    {
      "type": "dosing",
      "adult": {
        "Typical range": "Administered every 1–4 weeks via deep intramuscular injection; dose individualized based on prior oral dosing and clinical response."
      },
      "geriatric": "Lower initial doses recommended due to increased risk of side effects."
    },
    {
      "type": "dosage_forms",
      "items": [
        "Intramuscular injection (oil-based depot)"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Therapeutic effects begin within several days, with peak effect after steady-state is achieved over multiple doses; duration of effect is 1–4 weeks depending on dose."
    },
    {
      "type": "adverse_effects",
      "common": [
        "drowsiness",
        "dry mouth",
        "blurred vision",
        "constipation",
        "weight gain"
      ],
      "less_common": [
        "orthostatic hypotension",
        "akathisia",
        "tremor"
      ],
      "serious": [
        "tardive dyskinesia",
        "neuroleptic malignant syndrome",
        "prolonged QT interval"
      ]
    },
    {
      "type": "warnings",
      "black_box": "Increased mortality in elderly patients with dementia-related psychosis.",
      "other": [
        "Risk of tardive dyskinesia with long-term use",
        "Caution in patients with cardiovascular disease",
        "Caution in patients with hepatic impairment"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "CNS depressants",
          "risk": "Enhanced sedation and respiratory depression",
          "action": "Monitor closely"
        },
        {
          "with": "Anticholinergic drugs",
          "risk": "Increased anticholinergic effects",
          "action": "Monitor for constipation, urinary retention"
        },
        {
          "with": "QT-prolonging agents",
          "risk": "Additive cardiac risk",
          "action": "Avoid or monitor ECG"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Mental status and symptom control",
        "Signs of extrapyramidal symptoms",
        "Liver function tests",
        "ECG for patients at risk of QT prolongation"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Use only if benefits outweigh risks; phenothiazines cross the placenta.",
      "lactation": "Excreted in breast milk; avoid or use caution.",
      "geriatrics": "Greater sensitivity to sedation, orthostatic hypotension, and extrapyramidal symptoms."
    },
    {
      "type": "tapering",
      "text": "Gradual dose adjustments when discontinuing or switching to minimize withdrawal and symptom relapse."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Depot formulations are useful for improving adherence in patients with chronic psychotic disorders.",
        "Requires deep intramuscular administration by a healthcare professional."
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "DailyMed - Perphenazine Injection",
          "url": "https://dailymed.nlm.nih.gov/"
        },
        {
          "label": "Drugs.com - Perphenazine",
          "url": "https://www.drugs.com/perphenazine.html"
        }
      ]
    }
  ],
  "seo": {
    "title": "Perphenazine Enanthate - Long-Acting Injectable Antipsychotic",
    "description": "Perphenazine enanthate is a long-acting injectable antipsychotic used for schizophrenia and psychotic disorders. Learn about dosing, side effects, and warnings."
  }
}
